Evidence map›Paper›PMID 37356448›Full record

ArticleLancet (London, England)2023

Interventions to address global inequity in diabetes: international progress.

Ashby F Walker, Sian Graham, Louise Maple-Brown, Leonard E Egede, Jennifer A Campbell, Rebekah J Walker, Alisha N Wade, Jean Claude Mbanya, Judith A Long, Chittaranjan Yajnik and 5 more

Open access · greenAbstract read
In one paragraph

Article in Lancet (London, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
32.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Phenotypic and Genetic Diversity in Diabetes Across Populations.The Journal of clinical endocrinology and metabolism · 2025
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 10 institutions in 5 countries.

Ashby F WalkerDepartment of Health Services Research, Management and Policy, University of Florida, Gainesville, FL, USA.
Sian GrahamMenzies School of Health Research, Charles Darwin University, Darwin, NT, Australia.
Louise Maple-BrownMenzies School of Health Research, Charles Darwin University, Darwin, NT, Australia; Department of Endocrinology, Royal Darwin and Palmerston Hospitals, Darwin, NT, Australia.
Leonard E EgedeDepartment of General Internal Medicine, Center for Advancing Population Science, Medical College of Wisconsin, Milwaukee, WI, USA.
Jennifer A CampbellDepartment of General Internal Medicine, Center for Advancing Population Science, Medical College of Wisconsin, Milwaukee, WI, USA.
Rebekah J WalkerDepartment of General Internal Medicine, Center for Advancing Population Science, Medical College of Wisconsin, Milwaukee, WI, USA.
Alisha N WadeMRC/Wits Rural Public Health and Health Transitions Research Unit, Wits School of Public Health, University of the Witwatersrand, Johannesburg, South Africa; Division of Endocrinology, Diabetes and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Jean Claude MbanyaDivision of Endocrinology, Department of Internal Medicine and Specialties, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.
Judith A LongDivision of General Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Corporal Michael J Crescenz VA Medical Center, Philadelphia, PA, USA.
Chittaranjan YajnikDiabetes Unit, KEM Hospital Research Centre, Pune, India.
Nihal ThomasDepartment of Endocrinology, Christian Medical College, Vellore, India.
Osagie EbekozienT1D Exchange, Boston, MA, USA.
Oriyomi OdugbesanT1D Exchange, Boston, MA, USA.
Linda A DiMeglioDepartment of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA.
Shivani AgarwalFleischer Institute for Diabetes and Metabolism, Department of Endocrinology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY, USA; New York Regional Center for Diabetes Translation Research, Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address: shivani.agarwal@einsteinmed.edu.
Medical College of Wisconsin · UST1D Exchange · USUniversity of Pennsylvania · USAlbert Einstein College of Medicine · USCharles Darwin University · AUChristian Medical College & Hospital · INIndiana University School of MedicineMenzies School of Health Research · AUUniversité de Yaoundé I · CMUniversity of Florida · US

Funding

Translational Research Core - Engagement and Behavior ChangeP30DK111024 · NIDDK · EMORY UNIVERSITY · PI Mohammed Kumail Ali · 2016 to 2026
$13.4M
New York Regional Center for Diabetes Translation Research - Translational Intervention Methodology CoreP30DK111022 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI JEFFREY GONZALEZ · 2016 to 2026
$7.8M
HOME DM-BAT: Home-based Diabetes-Modified Behavioral Activation Treatment for Low Income Seniors with T2DM Diversity SupplementR01DK118038 · NIDDK · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI EGEDE, LEONARD E. · 2019 to 2023
$3.5M
Financial Incentives And Nurse Coaching to Enhance Diabetes Outcomes (FINANCE-DM) - Diversity SupplementR01DK120861 · NIDDK · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI EGEDE, LEONARD E. · 2019 to 2023
$3.4M
Lowering the Impact of Food insecurity in African American Adults with Type 2 Diabetes Mellitus (LIFT-DM) - Diversity SupplementR01MD013826 · NIMHD · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI EGEDE, LEONARD E., WALKER, REBEKAH J · 2019 to 2023
$3.4M
Structural Racism and Disparities in Social Risk, Human Capital, Health Care Resources, and Health Outcomes: A Multi-level Analysis of Pathways and Policy Levers for ChangeR01MD017574 · NIMHD · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI Leonard E. Egede, Sebastian Linde · 2023 to 2026
$2.5M
Impact of structural racism on hospital/clinic closures, community assets, and health outcomes in urban communitiesR01MD018012 · NIMHD · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI Leonard E. Egede, Sebastian Linde · 2023 to 2026
$2.4M
T1DTechCHW: Enhancing the Community Health Worker (CHW) Model to Promote Diabetes Technology Use in Young Adults from Underrepresented Minority Groups (YA-URMs) with Type 1 Diabetes (T1D)R01DK132302 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI AGARWAL, SHIVANI · 2022 to 2024
$1.0M
Identifying and Reducing Disparities in Outcomes Among Economically Vulnerable and Minority Young Adults with Type 1 DiabetesK23DK115896 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI AGARWAL, SHIVANI · 2018 to 2022
$988k
Conditional Cash Transfer Intervention to Improve Health Outcomes among Inner-City African Americans with T2DMK01DK131319 · NIDDK · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI Jennifer Annette Campbell · 2022 to 2026
$682k
Endocrine and metabolic diseases in rural South Africa-establishing burden and improving detectionK43TW010698 · FIC · WITS HEALTH CONSORTIUM (PTY), LTD · PI WADE, ALISHA NICOLE · 2017 to 2021
$581k
FIC NIH HHS K43 TW010698NIDDK NIH HHS K01 DK131319NIDDK NIH HHS K23 DK115896NIDDK NIH HHS P30 DK111022NIDDK NIH HHS P30 DK111024NIDDK NIH HHS R01 DK118038NIDDK NIH HHS R01 DK120861NIDDK NIH HHS R01 DK132302NIMHD NIH HHS R01 MD013826NIMHD NIH HHS R01 MD017574NIMHD NIH HHS R01 MD018012
6 · The paper itself

Abstract

Diabetes is a serious chronic disease with high associated burden and disproportionate costs to communities based on socioeconomic, gender, racial, and ethnic status. Addressing the complex challenges of global inequity in diabetes will require intentional efforts to focus on broader social contexts and systems that supersede individual-level interventions. We codify and highlight best practice approaches to achieve equity in diabetes care and outcomes on a global scale. We outline action plans to target diabetes equity on the basis of the recommendations established by The Lancet Commission on Diabetes, organising interventions by their effect on changing the ecosystem, building capacity, or improving the clinical practice environment. We present international examples of how to address diabetes inequity in the real world to show that approaches addressing the individual within a larger social context, in addition to addressing structural inequity, hold the greatest promise for creating sustainable and equitable change that curbs the global diabetes crisis.

Indexed as

Diabetes MellitusEcosystemHumansSocial Environment

Identifiers

PMID37356448
PMCPMC10726974
OpenAlexW4381743749

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.